This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dorothy Gemmell, Longtime Leader Of WebMD, Joins Havas Life New York As President

NEW YORK, Feb. 20, 2013 /PRNewswire/ -- Doug Burcin and Donna Murphy, global CEOs of Havas Health, today announce the appointment of Dorothy Gemmell to lead Havas Life New York. As the CEOs explain, " Dorothy Gemmell's availability presented us an opportunity to bring in a fresh leadership perspective on one of our most significant unified health and wellness agency brands. She will help us to drive continued agency growth and diversity. In leading Havas Life New York, Dorothy will stimulate staff to change faster to meet the evolving demands of clients, who have increasing pressure to deliver commercial success. We are thrilled that Dorothy accepted our offer to take over the reins of one of our most treasured agency properties.  She shares our commitment to a fully unified agency structure."

Dorothy Gemmell added, "Besides the opportunity to work with Doug and Donna, the factors that most enticed me to join Havas are the agency's commitment to provide fully unified marketing campaigns and then the great corporate culture here, which inspires passion, draws the most talented marketers together, and ensures that everyone is fully committed to driving the customers' business."

In the early days of the Internet, Gemmell developed a passion for its use in communicating clinical data to healthcare professionals, patients, advocates and caregivers and saw the power of the channel as transformational in health. "Havas' status as a leading social media agency and its focus on helping its clients leverage digital platforms for commercial success was another attractive attribute for me," said Gemmell.

Gemmell has more than 20 years of healthcare experience spanning biopharmaceuticals, medical education and digital healthcare, for which she has consistently built highly successful teams generating revenue with new customer bases. At WebMD, Gemmell's most recent role was senior vice president, sales and sales operations, as well as sitting on the company's executive leadership committee, which set the strategic priorities for the company and was directly responsible for leading WebMD's Global Biopharmaceutical and Medical Device businesses, WebMD The Magazine and its sales, revenue and advertising operations groups.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,806.58 -6.81 -0.04%
S&P 500 2,089.02 +0.15 0.01%
NASDAQ 5,119.70 +3.5570 0.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs